MT GENEX, Last Fiscal Year Ordinary Profit Revised Upward by 28%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri May 9, 2025 3:00 pm JST Revision

9820 MT GENEX CORPORATION 【J-GAAP】

Guidance Update Report

MT GENEX CORPORATION <9820> [TSE Std] announced a performance revision in the afternoon session on May 9th (15:00). The consolidated ordinary profit for the fiscal year ending March 2025 has been revised upward 27.9%, from the previous forecast of 337 million yen to 431 million yen (compared to 452 million yen in the previous period), and the declining rate is expected to decrease from 25.4% to 4.6%.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated ordinary profit is expected to increase 64.4%, from the previous forecast of 146 million yen to 240 million yen (compared to 192 million yen in the same period of the previous year), turning to a 25.0% increase in the consolidated ordinary profit outlook.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	1,984	143	146	87	80.8	40	Nov 8, 2024	J-GAAP
Oct - Mar, 2024 New	2,073	231	240	151	140.8	40	May 9, 2025	J-GAAP
Revision Rate	+4.5%	+61.5%	+64.4%	+73.6%	+74.2%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	3,861	322	337	200	185.8	40	May 13, 2024	J-GAAP
Mar, 2025 New	3,950	410	431	264	246.2	40	May 9, 2025	J-GAAP
Revision Rate	+2.3%	+27.3%	+27.9%	+32.0%	+32.5%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	1,769	185	192	117	108.9	40	May 13, 2024	J-GAAP
Oct - Mar, 2024 Guidance	2,073	231	240	151	140.8	40	May 9, 2025	J-GAAP
YoY	+17.2%	+24.9%	+25.0%	+29.1%	+29.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	3,263	364	382	241	224.5	40	May 12, 2023	J-GAAP
Mar, 2024	3,790	438	452	277	257.9	40	May 13, 2024	J-GAAP
Mar, 2025 Guidance	3,950	410	431	264	246.2	40	May 9, 2025	J-GAAP
YoY	+4.2%	-6.4%	-4.6%	-4.7%	-4.5%